Patents by Inventor Abhijit Mazumdar

Abhijit Mazumdar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of an RXR agonist and taxanes in treating Her2+ cancers
    Patent number: 11896558
    Abstract: The present specification provides improved methods of treating Her2+ cancers in which an RXR agonist and a taxane are administered to a subject having a Her2+ cancer. Thyroid hormone and other anticancer agents may also be administered. Related compositions and combination are also disclosed.
    Type: Grant
    Filed: December 7, 2022
    Date of Patent: February 13, 2024
    Assignees: Io Therapeutics, Inc., Board of Regents, The University of Texas System
    Inventors: Martin E. Sanders, Powel H. Brown, Cassandra Moyer, Abhijit Mazumdar
  • USE OF AN RXR AGONIST IN TREATING DRUG RESISTANT HER2+ CANCERS
    Publication number: 20230172890
    Abstract: The present specification provides combinations of active agents for the improved treatment of Her2+ cancers and associated methods of treatments. The combinations comprise an RXR agonist and a Her2-targeted therapeutic agent and may optionally further comprise thyroid hormone.
    Type: Application
    Filed: December 7, 2022
    Publication date: June 8, 2023
    Inventors: Martin E. Sanders, Powel H. Brown, Cassandra Moyer, Abhijit Mazumdar
  • USE OF AN RXR AGONIST AND TAXANES IN TREATING HER2+ CANCERS
    Publication number: 20230172872
    Abstract: The present specification provides improved methods of treating Her2+ cancers in which an RXR agonist and a taxane are administered to a subject having a Her2+ cancer. Thyroid hormone and other anticancer agents may also be administered.
    Type: Application
    Filed: December 7, 2022
    Publication date: June 8, 2023
    Inventors: Martin E. Sanders, Powel H. Brown, Cassandra Moyer, Abhijit Mazumdar
  • Mta1s, a steriod hormone receptor corepressor
    Publication number: 20060204957
    Abstract: The present invention concerns the use of methods and compositions to diagnose, treat and identify therapeutic molecules for cancer, in particular hormone insensitive cancers. The invention includes polypeptides and nucleic acids encoding polypeptides of MTA1s, a novel protein derived from alternative splicing of the MTA1 gene. Other embodiments include antibody compositions for the diagnosis and prognosis related to the aberrant expression of the MTA1s polypeptide.
    Type: Application
    Filed: May 1, 2003
    Publication date: September 14, 2006
    Inventors: Rakesh Kumar, Rui-An Wang, Abhijit Mazumdar, Ratna Vadlamudi